Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New approach to replacing immune cells shrink tumors in patients with melanoma


A new approach to cancer treatment that replaces a patient’s immune system with cancer-fighting cells can lead to tumor shrinkage, researchers report today in the journal Science*. The study demonstrates that immune cells, activated in the laboratory against patients’ tumors and then administered to those patients, can attack cancer cells in the body.

The experimental technique, known as adoptive transfer, has shown promising results in patients with metastatic melanoma who have not responded to standard treatment. With further research, scientists hope this approach may have applications to many cancer types, as well as infectious diseases such as AIDS.

In the study, 13 patients with metastatic melanoma (a deadly form of skin cancer) who had not responded to standard treatments were treated with immune cells produced in the laboratory specifically to destroy their tumors. The treatment resulted in at least 50 percent tumor shrinkage in six of the patients, with no growth or appearance of new tumors. Four additional patients had some cancer growths disappear.

Researchers have tried previously to treat cancer with immune cells but the cells did not survive well in the body. "In the past, only a fraction of a percent of the cells we injected were able to survive, and they would persist for only a few days," said Steven A. Rosenberg, M.D., Ph.D., of the National Cancer Institute, the lead researcher on the study.

Improvements in the way immune cells are generated in the laboratory and the way patients’ bodies are prepared to receive them, however, have led to dramatically different results. "We have been able to generate a very large number of immune cells that appear in the blood and constitute a majority of the immune system of the patient. These persist for over four months and are able to attack the tumor," Rosenberg said.

The adoptive transfer technique fights cancer with T cells, immune cells that recognize and kill foreign cells that have invaded the body. Researchers used a small fragment of each patient’s melanoma tumor to grow T cells in the laboratory, using T cells originally taken from the patients. Exposure to the tumor activated the immune cells so that they would recognize and attack cells from each specific cancer.

Once the T cells had multiplied to a sufficient number to be used for treatment, they were administered to patients. Patients were also given a high dose of a protein called interleukin-2 (IL-2), which stimulates continued T cell growth in the body. Prior to the immunotherapy, chemotherapy had been used to deplete patients’ own immune cells, which had proven ineffective at fighting the cancer. Diminishing the old cells provided an opportunity for the new T cells to repopulate patients’ immune systems. Analysis of blood and tumor samples from many of the patients who responded favorably to the treatment revealed that the administered immune cells were thriving, multiplying rapidly, and attacking tumor tissue. T cells activated against melanoma became the major component in patients’ immune systems. They persisted for several months and were able to destroy metastases throughout the body.

Over time, patients’ old immune systems recovered, restoring their ability to fight infections. Researchers report that among the patients in the study, only occasional opportunistic infections developed during treatment.

Other side effects were mild autoimmune disorders. T cells act by recognizing a protein fragment called an antigen on the outside of the tumor cells. Antigens found on tumor cells may also be found on certain normal cells in the body, making them vulnerable to attack. Autoimmune effects among the patients in the study were mild and easily controlled.

Although the treatment is highly experimental, researchers are optimistic that it may, in the future, extend beyond the treatment of patients with melanoma. It should be possible, they say, to raise immune cells that will recognize and attack many tumor types.

Similarly, the same technique could potentially be used to treat some infectious diseases, such as AIDS.

NCI Press Office | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Advanced analysis of brain structure shape may track progression to Alzheimer's disease
26.10.2016 | Massachusetts General Hospital

nachricht Indian roadside refuse fires produce toxic rainbow
26.10.2016 | Duke University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Greater Range and Longer Lifetime

26.10.2016 | Power and Electrical Engineering

VDI presents International Bionic Award of the Schauenburg Foundation

26.10.2016 | Awards Funding

3-D-printed magnets

26.10.2016 | Power and Electrical Engineering

More VideoLinks >>>